People being treated for cancer may be at elevated risk of developing severe cases of COVID-19. The coronavirus is also affecting how cancer care is delivered.
by William G. Nelson, MD, PhD
Cancer centers are taking advantage of their in-house molecular laboratories to selectively test certain cancer patients for the coronavirus.
by Anna Azvolinsky
From The Editor-In-Chief
Emerging insights into epigenetic abnormalities in cancer cells may lead to better cancer outcomes.
Procedure uses extreme cold to kill cancer cells.
by Christina Bennett
Studies provide little evidence to support this claim.
by Stephen Ornes
Updated guidelines support use of oral blood thinners.
by Jane Langille
Can eating yogurt reduce your risk of developing lung cancer?
by Karen Olsen
Science writer Charles Graeber describes how a shift in researchers’ understanding of immune function and cancer is leading to effective treatments.
by Marci A. Landsmann
Recommendations address conflicts and research gaps.
by Ashley P. Taylor
Patients may be wary of discussing this common side effect.
by Sue Rochman
The National Cancer Institute and the Food and Drug Administration have provided guidance for managing clinical trials amid the spread of the novel coronavirus. Cancer centers are making changes to care for some patients enrolled in trials.
A couple who lost their daughter to brain cancer builds a charity that connects parents, hospitals and researchers with data.
Approximately 18,440 Americans are expected to receive a diagnosis of esophageal cancer in 2020.
The Food and Drug Administration has approved a combination of two immunotherapy drugs to treat certain patients with liver cancer.
Cancer patients have a unique risk profile in this pandemic.
Handle With Care
donate to the AACR